comparemela.com

Extended Holter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA clears next-generation AI-powered ECG monitoring device

FDA clears next-generation AI-powered ECG monitoring device
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

HeartX Accelerator Names 5 Startups for 2023 Program

Each company will receive $150,000 of investment capital, along with access to clinicians and administrators while executing their pilot projects and clinical studies.

HeartX Accelerator Announces Five Startup Companies Selected for the 2023 Program

BENTONVILLE, Ark., October 16, 2023 HeartX, powered by HealthTech Arkansas and MedAxiom along with eleven leading cardiology practices in Arkansas and around the country — has selected the five startup healthcare companies that will participate in the 2023 accelerator program. HeartX is a cardiovascular-focused healthcare accelerator that facilitates guaranteed hospital pilot projects and clinical trials for accomplished, early-stage companies bringing new cardiovascular innovations to market.

HeartX selects five companies for tis accelerator program - Talk Business & Politics

HeartX selects five companies for tis accelerator program - Talk Business & Politics
talkbusiness.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from talkbusiness.net Daily Mail and Mail on Sunday newspapers.

InfoBionic Receives FDA 510(k) Clearance for its Next Generation MoMe ARC Solution

InfoBionic, the virtual telemetry company focused on efficiency and economics of cardiac remote patient monitoring, announces FDA 510(k) clearance for its MoMe ARC solution that encompasses our next generation remote ECG monitoring device and initial Bluetooth diagnostic 6-lead sensor designed to aid physicians in their diagnosis of cardiac arrhythmias. 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.